BIIB Income Statement
Biogen Inc - Revenue, Expenses & Profit Analysis
Stock Price
$178.30
Market Cap
$26.16B
P/E Ratio
16.3
EPS (TTM)
$10.97
Most Recent Quarter
Period: 2024-12-31(2024-12-31)
Revenue
Total sales from operations
$9.68B
-1.6% YoY
Net Income
Bottom line profit
$1.63B
Margin: 0.2%
Earnings Per Share (Diluted)
Net income per share
$11.18
Profitability Metrics
Gross Margin
76.6%
Operating Margin
0.3%
Net Margin
0.2%
Return on Equity
0.1%
Historical Income Statements
| Period | Revenue | Gross Profit | Operating Income | Net Income | EPS |
|---|---|---|---|---|---|
| 2024-12-31 | $9.68B | - | - | $1.63B | $11.18 |
| 2023-12-31 | $9.84B | - | - | $1.16B | $7.97 |
| 2022-12-31 | $10.17B | - | - | $2.96B | $20.87 |
| 2021-12-31 | $10.98B | - | - | $1.73B | $10.40 |
| 2020-12-31 | $2.85B | - | - | $357.60M | $2.32 |
View Complete Financial Analysis
Full income statements, balance sheets, cash flows, and AI-powered insights
Open Full AnalysisFrequently Asked Questions
What is BIIB's revenue?
BIIB's most recent quarterly revenue was $9.68B, representing a decline of 1.6% year-over-year.
Is BIIB profitable?
BIIB reported a profit of $1.63B in the most recent quarter. The net profit margin is 0.2%.
What is BIIB's operating income?
Operating income data is available in the income statement.
What is BIIB's earnings per share (EPS)?
BIIB reported diluted earnings per share of $11.18 in the most recent quarter.
What is BIIB's gross profit margin?
BIIB has a gross profit margin of 76.6%, indicating the profitability of core operations before operating expenses.